Immune Evasion, Tumor
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary (NCT05241132) | Wei Xu | 2021-11-12 |
| Immunoevasive Tactics Employed by Myeloid Malignancy After Allogeneic Stem Cell Transplantation (NCT03964922) | Central Hospital, Nancy, France | 2019-09-01 |
| Immune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer Origin (NCT03960021) | Institut Bergonié | 2019-03-04 |
Track Immune Evasion, Tumor automatically
Every clearance here is in the API, with alerts when new ones post.